NCT05595408
- Conditions
- Muscle Invasive Upper Tract Urothelial Carcinoma, Neoplasm, Residual, Neoplasms, +3 more
- Locations
-
- Renji Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Neoplastic Processes
Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.
3,266 public trials
688 recruiting studies
Neoplastic Processes trial results
NCT05338658
- Conditions
- Metastasis, Neoplasm Metastasis, Neoplasms, +4 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States
NCT05859074
- Conditions
- Adenocarcinoma, Adenocarcinoma, Sebaceous, Adnexal Carcinoma, +58 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
NCT07260370
- Conditions
- Circulating Tumor Cells, Immunotherapy, Neoplasm Metastasis, +6 more
- Locations
-
- Linkou Chang Gung Memorial Hospital Taoyuan City, Taiwan
NCT06623578
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +16 more
- Locations
-
- Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
NCT07021898
- Conditions
- Metastatic Solid Tumors, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- Sarah Cannon Research Institute (SCRI) Oncology Partners Nashville, Tennessee, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- NEXT Oncology Irving, Texas, United States
- NEXT Oncology San Antonio, Texas, United States
NCT06333314
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +28 more
- Locations
-
- Institut de Cancérologie de l'Ouest Angers, France
- Institut du Cancer Avignon-Provence Avignon, France
- CHU Jean Minjoz Besançon, France
- CHU Morvan Brest, France
Recruiting
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
NCT06912087
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +12 more
- Locations
-
- University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
NCT06201234
- Conditions
- Advanced or Metastatic Breast Cancer, BRCA1 Mutation, BRCA2 Mutation, +11 more
- Locations
-
- Vinzenz Von Paul Kliniken gGmbH - Marienhospital Stuttgart, Baden-Wurttemberg, Germany
- University Hospital Tübingen Tübingen, Baden-Wurttemberg, Germany
- Rems-Murr-Klinik-Winnenden Winnenden, Baden-Wurttemberg, Germany
- GRN Klinik Weinheim Weinheim, Baden-Württembergs, Germany
NCT07136181
- Conditions
- Disease Attributes, Eye Cancer, Eye Cancer, Intraocular Melanoma, +22 more
- Locations
-
- Honor Health Resarch Institute Scottsdale, Arizona, United States
- Sarah Cannon Research Institute (SCRI) - Denver HealthONE Location Denver, Colorado, United States
- SCRI Oncology Partners Nashville, Tennessee, United States